<DOC>
	<DOCNO>NCT00003317</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . Radiation therapy use high-energy x-rays damage tumor cell . It yet know combination chemotherapy effective without radiation therapy stage IIIA non-small cell lung cancer . PURPOSE : Randomized phase III trial compare effectiveness combination chemotherapy without radiation therapy treat patient stage IIIA non-small cell lung cancer surgically remove .</brief_summary>
	<brief_title>Combination Chemotherapy With Without Radiation Therapy Treating Patients With Stage IIIA Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Compare overall survival surgically resect patient limited stage IIIA non-small cell lung cancer treat postoperative chemotherapy without adjuvant radiotherapy . II . Compare failure free survival patient . III . Describe pattern local distant recurrence patient . IV . Determine toxicity associate chemotherapy without adjuvant radiotherapy patient . OUTLINE : This randomize , multicenter study . Four eight week surgery , patient receive paclitaxel IV 3 hour follow carboplatin IV 1-2 hour day 1 , 22 , 43 , 64 . Following completion four course chemotherapy , patient randomize one two treatment arm .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage IIIA nonsmall cell lung cancer completely resect lobectomy , bilobectomy , pneumonectomy , sleeve lobectomy incision ( thoracoscopic video assist resection acceptable ) No know residual disease present Involvement N2 node must determine time surgical exploration postoperative pathologic diagnosis All grossly involve node must remove surgery No positive mediastinoscopy ( lymph node CT scan great 1.5 cm diameter , mediastinoscopy require ) PATIENT CHARACTERISTICS : Age : 18 Performance status : ZUBROD 01 Life expectancy : Not specify Hematopoietic : Granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin le 1.5 mg/dL SGOT great upper limit normal Renal : Creatinine clearance least 20 mL/min Other : Not pregnant nursing PRIOR CONCURRENT THERAPY : Biologic therapy : No concurrent growth factor Chemotherapy : No prior chemotherapy nonsmall cell lung cancer No concurrent chemotherapy Endocrine therapy : No concurrent hormone therapy except : Steroids adrenal failure Hormones nondisease related condition Dexamethasone antiemetic Radiation therapy : No prior radiotherapy nonsmall cell lung cancer Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
</DOC>